Neogen (NEOG)
(Delayed Data from NSDQ)
$15.60 USD
-1.21 (-7.20%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $15.59 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum C VGM
Company Summary
Neogen Corporation develops and markets food and animal safety products. The company’s Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns.
Neogen operates under two business segments — Food Safety and Animal Safety.
Food Safety (70.9% of total revenues in fiscal 2024, up 6.6% from fiscal 2023): The products in the segment include tests for Mycotoxins, Food allergens, Waterborne microorganisms, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood ...
Company Summary
Neogen Corporation develops and markets food and animal safety products. The company’s Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns.
Neogen operates under two business segments — Food Safety and Animal Safety.
Food Safety (70.9% of total revenues in fiscal 2024, up 6.6% from fiscal 2023): The products in the segment include tests for Mycotoxins, Food allergens, Waterborne microorganisms, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants.
Animal Safety (29.1%, down 13.1%): The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. The majority of these consumable products are marketed through a network of national and international distributors, as well as a number of large farm supply retail chains in the United States and Canada.
The animal safety products include Veterinary instruments, Veterinary pharmaceuticals, Veterinary biologics, Veterinary OTC products, Rodenticides, Cleaners and disinfectants, Insecticides, Animal genomics services, Insect control products and Life sciences.
In September 2022, Neogen, 3M Company and Neogen Food Safety Corporation, a subsidiary created to carve out 3M’s Food Safety Division, closed on a transaction combining 3M’s Food Safety division with Neogen in a Reverse Morris Trust transaction and Neogen Food Safety Corporation became a wholly owned subsidiary of Neogen. Following the transaction, pre-merger Neogen Food Safety Corporation stockholders own approximately 50.1% of the issued and outstanding shares of Neogen common stock, and pre-merger Neogen shareholders own approximately 49.9% of the issued and outstanding shares of Neogen common stock.
General Information
Neogen Corporation
620 LESHER PLACE
LANSING, MI 48912
Phone: 517-372-9200
Fax: 517-372-2006
Email: ir@neogen.com
Industry | Medical - Products |
Sector | Medical |
Fiscal Year End | May |
Last Reported Quarter | 8/31/2024 |
Earnings Date | 10/10/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.10 |
Current Year EPS Consensus Estimate | 0.54 |
Estimated Long-Term EPS Growth Rate | NA |
Earnings Date | 10/10/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 16.81 |
52 Week High | 20.89 |
52 Week Low | 11.46 |
Beta | 1.21 |
20 Day Moving Average | 1,470,814.75 |
Target Price Consensus | 17.50 |
4 Week | -3.11 |
12 Week | 5.91 |
YTD | -22.43 |
4 Week | -6.16 |
12 Week | 3.46 |
YTD | -30.81 |
Shares Outstanding (millions) | 216.70 |
Market Capitalization (millions) | 3,380.49 |
Short Ratio | NA |
Last Split Date | 6/7/2021 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 28.89 |
Trailing 12 Months | 35.46 |
PEG Ratio | NA |
vs. Previous Year | -28.57% |
vs. Previous Quarter | -16.67% |
vs. Previous Year | -2.07% |
vs. Previous Quarter | 3.49% |
Price/Book | 1.07 |
Price/Cash Flow | 15.22 |
Price / Sales | 3.66 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 3.09 |
2/29/24 | 3.35 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 2.13 |
2/29/24 | 2.30 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 3.82 |
2/29/24 | 3.82 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 2.59 |
2/29/24 | 2.66 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 10.53 |
2/29/24 | 11.32 |
8/31/24 | Pending Next EPS Report |
5/31/24 | -1.02 |
2/29/24 | 0.17 |
8/31/24 | Pending Next EPS Report |
5/31/24 | -1.55 |
2/29/24 | -0.03 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 14.52 |
2/29/24 | 14.52 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 2.74 |
2/29/24 | 2.95 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 0.28 |
2/29/24 | 0.28 |
8/31/24 | Pending Next EPS Report |
5/31/24 | 22.03 |
2/29/24 | 22.00 |